Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Johnson and Johnson
Daiichi Sankyo
Cantor Fitzgerald

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202022

« Back to Dashboard

NDA 202022 describes EDURANT, which is a drug marketed by Janssen Prods and is included in one NDA. It is available from one supplier. There are six patents protecting this drug. Additional details are available on the EDURANT profile page.

The generic ingredient in EDURANT is rilpivirine hydrochloride. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the rilpivirine hydrochloride profile page.
Summary for 202022
Applicant:Janssen Prods
Ingredient:rilpivirine hydrochloride
Formulation / Manufacturing:see details
Pharmacology for NDA: 202022
Medical Subject Heading (MeSH) Categories for 202022
Suppliers and Packaging for NDA: 202022
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EDURANT rilpivirine hydrochloride TABLET;ORAL 202022 NDA Janssen Products, LP 59676-278 59676-278-01 30 TABLET, FILM COATED in 1 BOTTLE (59676-278-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 25MG BASE
Approval Date:May 20, 2011TE:RLD:Yes
Regulatory Exclusivity Expiration:Aug 26, 2018
Regulatory Exclusivity Use:NEW PATIENT POPULATION
Patent:➤ SubscribePatent Expiration:Feb 26, 2021Product Flag?YSubstance Flag?YDelist Request?
Patent:➤ SubscribePatent Expiration:Dec 20, 2019Product Flag?YSubstance Flag?YDelist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.